World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
16381
World Ranking
2156
National Ranking
149

Carmen Scheibenbogen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carmen Scheibenbogen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 321 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carmen Scheibenbogen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carmen Scheibenbogen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carmen Scheibenbogen is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily falls within the field of Medicine, with significant contributions to subfields such as Psychiatry and Mental Health, Neurology, Rehabilitation, Cellular and Molecular Neuroscience, and Infectious Diseases.

The scientist's work extensively covers topics including Fibromyalgia and Chronic Fatigue Syndrome Research, Long-Term Effects of COVID-19, Exercise and Physiological Responses, Genetic Neurodegenerative Diseases, COVID-19 and Mental Health, Health, Psychology, and Well-being, as well as COVID-19 Clinical Research Studies.

Frequent coauthors collaborating with Scheibenbogen include Claudia Kedor, Franziska Sotzny, Uta Behrends, Kirsten Wittke, and Helma Freitag.

Publications by Scheibenbogen have appeared in several key venues, with the highest number of contributions in bioRxiv (Cold Spring Harbor Laboratory), followed by Frontiers in Immunology, Journal of Clinical Medicine, Journal of Translational Medicine, and Nature Communications.

Recent papers include the following:

  • A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity (2022, Nature Communications)
  • Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) (2022, Journal of Translational Medicine)
  • European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe (2021, Medicina)
  • Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study (2022, EClinicalMedicine)
  • S1-Leitlinie Post-COVID/Long-COVID (2021, Pneumologie)

Best Publications

  • Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis

    H. G. Leser;V. Gross;C. Scheibenbogen;A. Heinisch

  • Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.

    Giulia Nizzoli;Jana Krietsch;Anja Weick;Svenja Steinfelder

  • Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

    Ulrich Keilholz;Jeffrey Weber;James H. Finke;Dmitry I. Gabrilovich

  • Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue

    Georg Wieczorek;Anne Asemissen;Fabian Model;Ivana Turbachova

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    Ulrich Keilholz;Anne Letsch;Antonia Busse;Anne Marie Asemissen

  • CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia.

    Carmen Scheibenbogen;Anne Letsch;Eckhard Thiel;Alexander Schmittel

  • Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

    Santa Rasa;Zaiga Nora-Krukle;Nina Henning;Eva Eliassen

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease

    Franziska Sotzny;Julià Blanco;Enrica Capelli;Jesús Castro-Marrero

  • Surface phenotype analysis of human monocyte to macrophage maturation.

    Reinhard Andreesen;Wolfram Brugger;Carmen Scheibenbogen;Marina Kreutz

  • Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.

    Madlen Loebel;Patricia Grabowski;Harald Heidecke;Sandra Bauer

  • Natural T cell immunity against cancer.

    Dirk Nagorsen;Carmen Scheibenbogen;Francesco M. Marincola;Anne Letsch

  • Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

    Ulrich Keilholz;Christian Conradt;Sewa S Legha;David Khayat

  • Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: A clinical report

    Marie Marchand;Marie Marchand;C. J.A. Punt;Steinar Aamdal;B. Escudier

  • Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

    U. Keilholz;Swan Hoo Goey;C. J. A. Punt;T. M. Proebstle

  • Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

    V Mailänder;C Scheibenbogen;E Thiel;A Letsch

  • Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

    Unknown

  • Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory

    Anna Okhrimenko;Joachim R. Grün;Kerstin Westendorf;Zhuo Fang

  • Quantitation of antigen-reactive T cells in peripheral blood by IFNγ-ELISPOT assay and chromium-release assay: a four-centre comparative trial

    Carmen Scheibenbogen;Pedro Romero;Licia Rivoltini;Wolfgang Herr

  • CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.

    O Penack;C Gentilini;L Fischer;A M Asemissen

  • Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

    Carmen Scheibenbogen;Alexander Schmittel;Ulrich Keilholz;Thomas Allgäuer

  • A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood.

    Peter Brossart;Johann-W. Schmier;Stefan Krüger;Martina Willhauck

  • Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells

    Licia Rivoltini;Chiara Castelli;Matteo Carrabba;Vincenzo Mazzaferro

  • Analysis of the T cell response to tumor and viral peptide antigens by an IFNγ‐ELISPOT assay

    Carmen Scheibenbogen;Kang-Hun Lee;Stefan Stevanovic;Mathias Witzens

Frequent Co-Authors

Eckhard Thiel
Eckhard Thiel Charité - University Medicine Berlin
Ulrich Keilholz
Ulrich Keilholz Charité - University Medicine Berlin
Hans-Dieter Volk
Hans-Dieter Volk Charité - University Medicine Berlin
Heinz-Peter Schultheiss
Heinz-Peter Schultheiss Charité - University Medicine Berlin
Bernd Dörken
Bernd Dörken Charité - University Medicine Berlin
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin
Klemens Ruprecht
Klemens Ruprecht Charité - University Medicine Berlin
Petra Reinke
Petra Reinke Berlin-Brandenburger Centrum für Regenerative Therapien
Wolfram Doehner
Wolfram Doehner Charité - University Medicine Berlin
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open up diverse career pathways in healthcare. If you're interested in expanding your clinical skills, accelerated nurse practitioner programs offer a fast track to advanced practice roles, combining rigorous training with flexible online coursework.

Alternatively, many students without a nursing background consider enrolling in the best online BSN programs for non nurses, which provide a solid foundation in nursing tailored specifically for career changers.

For quicker entry into the nursing field, 12-month accelerated nursing programs can be an excellent option. These programs are designed for those seeking an intensive, time-efficient path to becoming a registered nurse.

Additionally, the fastest and easiest LPN programs provide entry-level nursing credentials in a shorter timeframe, ideal for individuals looking to start their healthcare careers swiftly.

Choosing any of these online programs can complement your immunology background and broaden your employment opportunities in healthcare and research sectors.

Best Scientists Citing Carmen Scheibenbogen

Trending Scientists

Recently Published Articles